Scott Bradfield

Interim Division Chief

Nemours Children's Health System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Scott Bradfield is the Interim Division Chief at Nemours Children's Health System in the United States. His research focuses on pediatric oncology, particularly in areas such as symptom management in pediatric cancer, the efficacy and safety of treatment modalities for various sarcomas, and the implications of SARS-CoV-2 on childhood cancer patients. His recent publications reflect a commitment to advancing care standards and improving treatment outcomes for children with cancer.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Scott Bradfield

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Factors Associated With Symptom Burden Among Pediatric Patients With Cancer

Care Pathway– and Guideline-Consistent Care in Pediatric Cancer Symptom Management

Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcoma

Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the University of Florida Experience

Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience

A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors

Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor

SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities.

Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation.

Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis.

Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.

Collaborators (5)

Daniel Runco

Julie Bradley

Akash Parekh

Melissa P. Beauchemin

Scott Borinstein

Make your next move.